Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2899
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. What?? He shot high profile Minnesota politicians. I >feel like< you’re wrong.
  2. Tommy Nobis was the first pick in the 1966 NFL draft going to the first year expansion team Atlanta Falcons. He toiled (and toiled is the right word) for 11 years leading the defense on immemorable Atlanta teams. He’s got to be on that list.
  3. God only knows what we’ll be without Brian Wilson.
  4. Stand for the things you know are right It's the truth that the truth makes them so uptight Stand, all the things you want are real You have you to complete and there is no deal
  5. Today may not be >thee< day, but it ain’t bad. UUUU +.41 to 5.87, EOSE +.46 to 4.30, and IBRX +.23 to 3.38. Holding 15,000 shrs of UUUU @6.48, 15,100 shrs of EOSE @5.79, and 32,800 shrs of IBRX @8.85.
  6. Kharkiv high school graduation photo taken in the ruins of her high school. Fuck you, Putin.
  7. Casey Hampton starter kit
  8. If there are no dogs in heaven, then when I die, I want to go where they went. @Derka Chief’s waiting on the other side.
  9. Revelry….and relief.🤘
  10. Our. Day. Will. Come.
  11. I just read you’re only supposed to double down when fundamentals are sound. Whoops.
  12. ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer https://www.businesswire.com/news/home/20250603288322/en/ASCO-Report-of-Pioneering-Treatment-of-Lymphopenia-with-Significant-Overall-Survival-Benefit-in-Advanced-Pancreatic-Cancer Higher revenues for IBRX should be in the cards with all the news from the past 5 days.
  13. This is what happens when you try to play big league ball with little league bats.
  14. Sold 1/4 of my UUUU position and bought 6100 shares of EOSE @ 4.10 leaving 15,000 shrs of UUUU and 15,100 shrs of EOSE. I think EOSE’s batteries will be adopted by more utility scale players even with the green agenda struggling under Trump. It doesn’t hurt that David Urban was appointed to EOSE’s BOD in December.
  15. The interview with IBRX owner/Executive Chairman Patrick Soon-Shiong begins around 9:30. At 26:30, PSS says BioShield will be brought to Saudi Arabia, the Middle East, and Africa within 90 days. I want to believe the Saudis are immune to the power, influence, and money of Big Pharma.
  16. Cancer BioShield Platform Comes to Saudi Arabia and the Middle East May 27, 2025 • 11:36 am CDT ImmunityBio, Inc (IBRX), today announced the signing of a strategic Memorandum of Understanding (MOU) with the Ministry of Investment of Saudi Arabia (MISA), King Faisal Specialist Hospital & Research Centre (KFSHRC), and King Abdullah International Medical Research Center (KAIMRC). As of May 27, 2025, this multi-party collaboration will introduce the FDA-approved Cancer BioShield platform to Saudi Arabia and the broader Middle East, marking a new era of immune-restorative therapies for cancer patients. Dr. Patrick Soon-Shiong, Founder, Executive Chairman, and Global Chief Medical and Scientific Officer of ImmunityBio, stated in a press release, “We are honored to work with KAIMRC, KFSHRC, and MISA to bring this transformative technology to the region." "The BioShield platform changes the way we think about treating cancer, not by destroying the immune system but by restoring and activating it." "The root cause of early mortality is the collapse of the immune system—lymphopenia is the disease, and cancer is a symptom." "Together, by considering this a paradigm change, we can build a regional center of excellence for next-generation immunotherapies in which we activate the body’s natural defenses.” The BioShield platform, powered by Anktiva (nogapendekin alfa inbakicept)—the world’s first FDA-approved IL-15 superagonist to stimulate the proliferation of NK and T cells (lymphocytes)—represents a paradigm shift in cancer care. Unlike conventional treatments, such as chemotherapy and radiation, which kill and suppress natural killer immune cells, thereby paradoxically catalyzing further spread, BioShield protects and activates the immune system’s natural killer cells and T cells to restore immune function and prolong life. For the first time in medicine, physicians can address the long-overlooked impact of lymphopenia (loss of NK and T cells), induced by current standards of care of chemotherapy, radiation, or by the cancer itself. The BioShield is the first therapy in history to specifically address the protection and restoration of lymphocytes, represented by NK, CD8, and CD4 T cells—the most important cells in the body needed to fight cancer and infection. Treating lymphopenia is an answer to premature death from life-threatening diseases such as cancer and sepsis, and, potentially, to aging and longevity in health. As of May 2025, Anktiva plus BCG Vaccine is available at various clinical sites in the U.S. **Mentioning dollar amounts for revenue or any royalty amounts involved would’ve helped the sp of IBRX (which did nada yesterday and has gotten way too comfortable doing nada). US technology going overseas and it will be a foreign country approving Bioshield first for Lymphophenia. When the Saudi Food and Drug Authority does issue that approval for their citizens and the Middle East, it will make the FDA look like the idiots that they are considering the FDA has had the Lymphophenia data for some time.
  17. Crosstown Traffic by Hendrix. Nice bumper mzk.
  18. Their bottom of the order hitting HR’s. No esta bien, amigos.
×
×
  • Create New...